Nabi Biopharmaceuticals (PentaStaph vaccine program)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A license for developing vaccine in Rockville, Maryland. The licence features development rights of a vaccine namely, PentaStaph, to be used against staphylococcal infections.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 12270 Wilkins Avenue
- Rockville, MD 20852
- United States
Nabi Biopharmaceuticals (PentaStaph vaccine program) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Nabi Biopharmaceuticals (PentaStaph vaccine program)‘s full profile, request access.
Request full access to PitchBookNabi Biopharmaceuticals (PentaStaph vaccine program) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Nabi Biopharmaceuticals (PentaStaph vaccine program)‘s full profile, request access.
Request full access to PitchBook